# Anne‐Marie C. Dingemans

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anne-marie-c-dingemans/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,244 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 72 |
| i10-index | 264 |
| Last Known Institution | Erasmus MC |
| OpenAlex ID | https://openalex.org/A5016567527 |
| ORCID iD | https://orcid.org/0000-0001-6105-182X |
| Works | 659 |

## Researcher papers

- [Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation](https://scholariq.org/papers/characterisation-and-classification-of-oligometastatic-disease-a-european/)
- [COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study](https://scholariq.org/papers/covid-19-in-patients-with-thoracic-malignancies-teravolt-first-results-of-an/)
- [Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/small-cell-lung-cancer-esmo-clinical-practice-guidelines-for-diagnosis-treatment/)
- [Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer](https://scholariq.org/papers/tarlatamab-for-patients-with-previously-treated-small-cell-lung-cancer/)
- [Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial](https://scholariq.org/papers/tepotinib-plus-gefitinib-in-patients-with-egfr-mutant-non-small-cell-lung-cancer/)
- [Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors](https://scholariq.org/papers/outcome-of-patients-with-non-small-cell-lung-cancer-and-brain-metastases-treated/)
- [Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids](https://scholariq.org/papers/integrative-and-comparative-genomic-analyses-identify-clinically-relevant/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

## Researcher university

- [Erasmus MC](https://scholariq.org/institutions/erasmus-mc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.